Eleva Capital SAS
Latest statistics and disclosures from Eleva Capital SAS's latest quarterly 13F-HR filing:
Tip: Access up to 7 years of quarterly data
Positions held by Eleva Capital SAS consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Eleva Capital SAS
Eleva Capital SAS holds 24 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| CRH Ord (CRH) | 81.3 | $279M | 2.7M | 105.12 |
|
|
| Amer Sports Com Shs (AS) | 2.9 | $9.8M | 299k | 32.92 |
|
|
| NVIDIA Corporation (NVDA) | 2.6 | $9.1M | 52k | 174.40 |
|
|
| Netflix (NFLX) | 2.4 | $8.4M | 87k | 96.15 |
|
|
| Alphabet Cap Stk Cl A (GOOGL) | 2.3 | $8.0M | 28k | 287.56 |
|
|
| Taiwan Semiconductor Mfg Lt Sponsored Ads (TSM) | 1.9 | $6.5M | 21k | 303.89 |
|
|
| Arista Networks Com Shs (ANET) | 1.7 | $5.8M | 47k | 122.78 |
|
|
| Amazon (AMZN) | 1.0 | $3.4M | 16k | 208.27 |
|
|
| Metropcs Communications (TMUS) | 0.9 | $3.0M | 14k | 210.03 |
|
|
| Robinhood Mkts Com Cl A (HOOD) | 0.6 | $2.2M | 32k | 69.30 |
|
|
| On Hldg Namen Akt A (ONON) | 0.5 | $1.7M | 50k | 34.02 |
|
|
| Boston Scientific Corporation (BSX) | 0.5 | $1.7M | 27k | 62.75 |
|
|
| Spotify Technology S A SHS (SPOT) | 0.4 | $1.3M | 2.7k | 484.91 |
|
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.2 | $823k | 26k | 32.01 |
|
|
| Cg Oncology (CGON) | 0.2 | $561k | 8.3k | 67.68 |
|
|
| Esperion Therapeutics (ESPR) | 0.1 | $502k | 183k | 2.74 |
|
|
| Mineralys Therapeutics (MLYS) | 0.1 | $463k | 17k | 27.09 |
|
|
| Fennec Pharmaceuticals (FENC) | 0.1 | $327k | 53k | 6.15 |
|
|
| Disc Medicine (IRON) | 0.1 | $327k | 5.1k | 63.94 |
|
|
| Miragen Therapeutics (VRDN) | 0.0 | $139k | 7.1k | 19.56 |
|
|
| Freeport Mcmoran CL B (FCX) | 0.0 | $133k | 2.3k | 58.78 |
|
|
| Archer Aviation Com Cl A (ACHR) | 0.0 | $111k | 22k | 5.17 |
|
|
| Edgewise Therapeutics (EWTX) | 0.0 | $55k | 18k | 3.15 |
|
|
| Aquestive Therapeutics (AQST) | 0.0 | $11k | 2.7k | 4.15 |
|
Past Filings by Eleva Capital SAS
SEC 13F filings are viewable for Eleva Capital SAS going back to 2025
- Eleva Capital SAS 2026 Q2 filed July 2, 2026
- Eleva Capital SAS 2026 Q1 filed April 15, 2026
- Eleva Capital SAS 2025 Q3 filed Nov. 10, 2025
- Eleva Capital SAS 2025 Q2 filed Aug. 5, 2025